Strategies aimed at reprogramming immune cell metabolism—such as targeting fatty acid oxidation (FAO) in TAMs, inhibiting neutrophil elastase to reduce TAN pro-tumor effects, and modulating cytokine production—can shift the immune balance toward anti-tumor activity. This evidence concerns the gene ELANE and neoplasm.